检测黄斑病变视网膜内和视网膜下积液所需的最低光学相干断层扫描B扫描密度
研究纳入150例接受玻璃体腔抗血管内皮生长因子治疗的连续患者,在监测访视时使用扫描野20°×20°、97条B扫描、扫描间距60微米的光谱域光学相干断层扫描。通过逐次删除隔条B扫描生成扫描间距120微米(49条)、240微米(25条)和480微米(13条)的数据集,由两名独立评估者判断视网膜内囊样空间和视网膜下积液。结果显示扫描间距增至240微米不影响治疗相关渗出性视网膜改变的检测,而480微米时敏感性显著下降。
要点
- 扫描间距120微米和240微米检测视网膜内和/或视网膜下积液的敏感性分别为99.0%和97.1%,与60微米无显著差异。
- 扫描间距480微米检测敏感性降至87.4%,与60微米相比差异有统计学意义(P=0.0001)。
- 扫描间距增至240微米不影响治疗相关渗出性视网膜改变的检测。
核心结论
- 扫描间距增至240微米不会显著影响黄斑疾病玻璃体腔治疗监测中治疗相关渗出性视网膜改变的检测。
研究设计与样本
- 研究纳入150只眼(150例连续患者),在玻璃体腔抗血管内皮生长因子治疗监测访视时行光谱域光学相干断层扫描(Spectralis;Heidelberg Engineering,海德堡,德国),扫描野20°×20°、97条B扫描、扫描间距60微米。
- 通过定制软件逐次删除隔条B扫描生成扫描间距120微米(49条)、240微米(25条)、480微米(13条)的数据集,由两名独立评估者判断视网膜内积液囊样空间和视网膜下积液。
主要发现
- 治疗诊断为新发血管性年龄相关性黄斑变性占68.0%、视网膜静脉阻塞继发黄斑水肿占20.7%、糖尿病性黄斑水肿占10.7%、其他视网膜疾病占4.0%。
- 扫描间距60微米源数据集检测视网膜内积液为56.0%、视网膜下积液为19.3%、任一或两者为68.7%。
- 扫描间距120微米、240微米、480微米检测视网膜内和/或视网膜下积液的敏感性分别为99.0%(95%CI 94.7-100.0;P=0.5)、97.1%(95%CI 91.7-99.4;P=0.1)、87.4%(95%CI 79.4-93.1;P=0.0001)。
临床怎么用
- 作者认为这些发现对常规临床诊疗和干预性临床研究中光学相干断层扫描B扫描密度的选择具有相关性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the minimal optical coherence tomography B-scan density for reliable detection of intraretinal and subretinal fluid. METHODS: Spectral domain optical coherence tomography raster scanning (Spectralis; Heidelberg Engineering, Heidelberg, Germany) using a scan field of 20° × 20° of 97 B-scans with an interscan distance (ISD) of 60 μm was performed in 150 eyes of 150 consecutive patients at monitoring visits for intravitreal anti-vascular endothelial growth factor therapy. Using custom software, every other B-scan was repeatedly deleted to generate additional data sets with an ISD of 120 μm (49 B-scans), 240 μm (25 B-scans), and 480 μm (13 B-scans). Two independent reviewers evaluated the data sets for the presence of cystoid spaces of intraretinal fluid and subretinal fluid. RESULTS: Treatment diagnoses were neovascular age-related macular degeneration (68.0%), macular edema secondary to retinal vein occlusion (20.7%), diabetic macular edema (10.7%), and other retinal diseases (4.0%). Using the source data sets with an ISD of 60 μm, intraretinal fluid was detected in 56.0%, subretinal fluid in 19.3%, and either/both in 68.7%. Compared with these results, the sensitivity of detection of intraretinal fluid and/or subretinal fluid using an ISD of 120 μm, 240 μm, and 480 μm was 99.0% (95% confidence interval, 94.7-100.0; P = 0.5), 97.1% (91.7-99.4; P = 0.1), and 87.4% (79.4-93.1; P = 0.0001), respectively. CONCLUSION: An increase of ISD up to 240 μm does not significantly impair the detection of treatment-relevant exudative retinal changes in monitoring during intravitreal therapy of macular diseases. These findings are relevant for the choice of optical coherence tomography B-scan density in both routine clinical care and interventional clinical studies.
引用
- Fang PP, Domdei N, Herrmann P, et al. MINIMAL OPTICAL COHERENCE TOMOGRAPHY B-SCAN DENSITY FOR RELIABLE DETECTION OF INTRARETINAL AND SUBRETINAL FLUID IN MACULAR DISEASES. Retina. 2019. PMID: 29095359. doi:10.1097/IAE.0000000000001918
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。